Loading organizations...
Pharmaceutical company developing glaucoma therapies.
Tisbury Pharmaceuticals has raised $32.0M across 1 funding round.
Tisbury Pharmaceuticals has raised $32.0M in total across 1 funding round.
Tisbury Pharmaceuticals has raised $32.0M in total across 1 funding round.
Tisbury Pharmaceuticals's investors include Emmett Cunningham, Marten Steen, Nissim Darvish MD, DSc, Pontifax.
Tisbury Pharmaceuticals has raised $32.0M across 1 funding round. Most recently, it raised $32.0M Series A in June 2017.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 16, 2017 | $32.0M Series A | Emmett Cunningham, Marten Steen, Nissim Darvish MD, DSc | Pontifax |